Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method.

An efficient method for constructing a recombinant adenovirus (Ad) vector, based on an in vitro ligation, has been developed. To insert the foreign gene into an adenoviral DNA, we introduced three unique restriction sites, I-CeuI, SwaI, and PI-SceI, into the E1 deletion site of the vector plasmid, which contains a complete E1, E3-deleted adenovirus type 5 genome. I-CeuI and PI-SceI are intron-encoded endonucleases with a sequence specificity of at least 9-10 and 11 bp, respectively. A shuttle plasmid, pHM3, containing multiple cloning sites between the I-CeuI and PI-SceI sites, was constructed. After the gene of interest was inserted into this shuttle plasmid, the plasmid for E1-deleted adenovirus vector could be easily prepared by in vitro ligation using the I-CeuI and PI-SceI sites. SwaI digestion of the ligation products prevented the production of a plasmid containing a parental adenovirus genome (null vector). After transformation into E. coli, more than 90% of the transformants had the correct insert. To make the vector, a PacI-digested, linearized plasmid was transfected into 293 cells, resulting in a homogeneous population of recombinant virus. The large number and strategic location of the unique restriction sites will not only increase the rapidity of production of new first-generation vectors for gene transfer but will allow for rapid further improvements in the vector DNA backbone.

[1]  S. Kochanek,et al.  Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. , 2000, Human gene therapy.

[2]  D. Cook,et al.  Studying heterotrimeric G‐protein‐linked signal transduction using replication‐deficient adenoviruses , 2000, Immunology and cell biology.

[3]  F. Graham,et al.  An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. , 2000, Human gene therapy.

[4]  M. Kay,et al.  A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. , 1999, Human gene therapy.

[5]  F. Graham,et al.  High-efficiency Cre/loxp based system for construction of adenovirus vectors , 1999 .

[6]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Deisseroth,et al.  Use of the cosmid adenoviral vector cloning system for the in vitro construction of recombinant adenoviral vectors. , 1997, Human gene therapy.

[8]  M. Perricaudet,et al.  Recombinational construction in Escherichia coli of infectious adenoviral genomes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Kay,et al.  Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo , 1996, Journal of virology.

[10]  M. Mehtali,et al.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli , 1996, Journal of virology.

[11]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Kay,et al.  Therapeutic serum concentrations of human alpha‐1‐antitrypsin after adenoviral‐mediated gene transfer into mouse hepatocytes , 1995, Hepatology.

[13]  M. Kay,et al.  Gene therapy for metabolic disorders , 1995 .

[14]  F. Graham,et al.  An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Kay,et al.  Gene therapy for metabolic disorders. , 1994, Trends in genetics : TIG.

[16]  F. Spencer,et al.  Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Wilson,et al.  Gene therapy: adenovirus vectors. , 1993, Current opinion in genetics & development.

[18]  P. Macdonald,et al.  Formation of germ cells in Drosophila. , 1993, Current opinion in genetics & development.

[19]  M. Kay,et al.  Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo , 1992 .

[20]  J. Thorner,et al.  Homing of a DNA endonuclease gene by meiotic gene conversion in Saccharomyces cerevisiae , 1992, Nature.

[21]  C. Lemieux,et al.  Cleavage pattern of the homing endonuclease encoded by the fifth intron in the chloroplast large subunit rRNA-encoding gene of Chlamydomonas eugametos. , 1991, Gene.

[22]  M. Perricaudet,et al.  Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. , 1991, Science.

[23]  M. Perricaudet,et al.  Expression of human α1‐antitrypsin using a recombinant adenovirus vector , 1990 .

[24]  M. Perricaudet,et al.  Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector. , 1990, FEBS letters.

[25]  P. Sharp,et al.  Generation of adenovirus by transfection of plasmids. , 1983, Nucleic acids research.